Alzamend Neuro Inc (ALZN) earnings: date, estimates, results and stock reactions
Next earnings: Q2 FY2027 on 2026-12-08 (expected, time not announced). EPS estimate -0.23, revenue estimate n/a.
Over the last 12 reports the stock moved 5.1% on average (either way), rising 2 times and falling 10. EPS beat estimates 6 of 12 times; revenue 0 of 0. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q1 FY2027 | 2026-09-10 | -0.68 | -0.56 | -21.4% | n/a | n/a | +2.4% |
| Q4 FY2026 | 2026-07-22 | -0.74 | -0.67 | -10.4% | n/a | n/a | -4.5% |
| Q3 FY2026 | 2026-03-11 | -0.58 | -0.53 | -9.4% | n/a | n/a | -2.3% |
| Q2 FY2026 | 2025-12-09 | -0.30 | -0.83 | +63.9% | n/a | n/a | -4.0% |
| Q1 FY2026 | 2025-09-10 | -1.28 | -3.69 | +65.3% | n/a | n/a | +1.3% |
| Q4 FY2025 | 2025-07-29 | -2.36 | -2.70 | +12.6% | n/a | n/a | -9.0% |
| Q3 FY2025 | 2025-03-10 | -1.71 | -2.61 | +34.5% | n/a | n/a | -8.2% |
| Q2 FY2025 | 2024-12-11 | -3.60 | -21.42 | +83.2% | n/a | n/a | -3.3% |